Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF615 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTGDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
METTL13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C18orf25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK5R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD34A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCL1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYPD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on